OxyPharma Report issue

For profit Phase 2
Founded: Stockholm Sweden (2002)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2007
NCT00525213
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now